Lisinopril and Hydrochlorothiazide Tablets USP recall
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202…
Why was Lisinopril and Hydrochlorothiazide Tablets USP recalled?
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: QA01081, Exp. Date April 2027
- Product
- Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202…
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Quantity
- 58,968 bottles
- Distribution
- Product was distributed nationwide within the United States.
- Recall date
- July 23, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)